Sustained MYB activity drives emergent enhancer activation and precise enhancer-promoter interactions
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 81 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Samples
- 81 samples: 21 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- MYB activity drives emergent enhancer activation and enhancer-promoter interactions in acute lymphoblastic leukemiaBlood · 2026
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE296242_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1258259 and SRA study SRP582681. Searching any of these in the dataset finder brings you back here.
Supports a case/control comparison: 5 samples read as cases, 8 as controls.
How we read this: 21 replicated groups read from 81 sample titles; they account for 61 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8965986 ATAC-seq in E14 (TOT2N variant) cells containing stable integration of TetR constuct, replicate 1 ATAC-seq in E14 (TOT2N …
- GSM8965987 ATAC-seq in E14 (TOT2N variant) cells containing stable integration of TetR constuct, replicate 2 ATAC-seq in E14 (TOT2N …
- GSM8965988 ATAC-seq in E14 (TOT2N variant) cells containing stable integration of TetR constuct, replicate 3 ATAC-seq in E14 (TOT2N …
- GSM8965989 ATAC-seq in E14 (TOT2N variant) cells containing stable integration of TetR-MYBTA constuct, replicate 1 ATAC-seq in E14 (TOT2N …
- GSM8965990 ATAC-seq in E14 (TOT2N variant) cells containing stable integration of TetR-MYBTA constuct, replicate 2 ATAC-seq in E14 (TOT2N …
- GSM8965991 ATAC-seq in E14 (TOT2N variant) cells containing stable integration of TetR-MYBTA constuct, replicate 3 ATAC-seq in E14 (TOT2N …
- GSM8965992 ATAC-seq in wild type E14 (TOT2N variant) cells, replicate 1 ATAC-seq in wild type E…
- GSM8965993 ATAC-seq in wild type E14 (TOT2N variant) cells, replicate 2 ATAC-seq in wild type E…
- GSM8965994 ATAC-seq in wild type E14 (TOT2N variant) cells, replicate 3 ATAC-seq in wild type E…
- GSM8966021 Capture-C in E14 (TOT2N variant) cells with rTetR-MybTA construct, replicate 1 Capture-C in E14 (TOT2N…
- GSM8966022 Capture-C in E14 (TOT2N variant) cells with rTetR-MybTA construct, replicate 2 Capture-C in E14 (TOT2N…
- GSM8966023 Capture-C in E14 (TOT2N variant) cells with rTetR-MybTA construct, replicate 3 Capture-C in E14 (TOT2N…
- GSM8966024 Capture-C in E14 (TOT2N variant) cells with rTetR-MybTA construct +30min doxcycline, replicate 1
- GSM8966025 Capture-C in E14 (TOT2N variant) cells with rTetR-MybTA construct +30min doxcycline, replicate 2 Capture-C in E14 (TOT2N…
- GSM8966026 Capture-C in E14 (TOT2N variant) cells with rTetR-MybTA construct +30min doxcycline, replicate 3 Capture-C in E14 (TOT2N…
- GSM8966027 Capture-C in E14 (TOT2N variant) cells with TetR-MybTA construct, replicate 1, sequencing run 1 Capture-C in E14 (TOT2N…
- GSM8966028 Capture-C in E14 (TOT2N variant) cells with TetR-MybTA construct, replicate 1, sequencing run 2 Capture-C in E14 (TOT2N…
- GSM8966029 Capture-C in E14 (TOT2N variant) cells with TetR-MybTA construct, replicate 1, sequencing run 3 Capture-C in E14 (TOT2N…
- GSM8966030 Capture-C in E14 (TOT2N variant) cells with TetR-MybTA construct, replicate 2, sequencing run 1 Capture-C in E14 (TOT2N…
- GSM8966031 Capture-C in E14 (TOT2N variant) cells with TetR-MybTA construct, replicate 2, sequencing run 2 Capture-C in E14 (TOT2N…
- GSM8966032 Capture-C in E14 (TOT2N variant) cells with TetR-MybTA construct, replicate 2, sequencing run 3 Capture-C in E14 (TOT2N…
- GSM8966033 Capture-C in E14 (TOT2N variant) cells with TetR-MybTA construct, replicate 3, sequencing run 1 Capture-C in E14 (TOT2N…
- GSM8966034 Capture-C in E14 (TOT2N variant) cells with TetR-MybTA construct, replicate 3, sequencing run 2 Capture-C in E14 (TOT2N…
- GSM8966035 Capture-C in E14 (TOT2N variant) cells with TetR-MybTA construct, replicate 3, sequencing run 3 Capture-C in E14 (TOT2N…
- GSM8966036 Capture-C in E14 (TOT2N variant) cells with TetR-MybTA construct +1h doxycycline, replicate 1, sequencing run 1 Capture-C in E14 (TOT2N…
- GSM8966037 Capture-C in E14 (TOT2N variant) cells with TetR-MybTA construct +1h doxycycline, replicate 1, sequencing run 2 Capture-C in E14 (TOT2N…
- GSM8966038 Capture-C in E14 (TOT2N variant) cells with TetR-MybTA construct +1h doxycycline, replicate 1, sequencing run 3 Capture-C in E14 (TOT2N…
- GSM8966039 Capture-C in E14 (TOT2N variant) cells with TetR-MybTA construct +1h doxycycline, replicate 2, sequencing run 1 Capture-C in E14 (TOT2N…
- GSM8966040 Capture-C in E14 (TOT2N variant) cells with TetR-MybTA construct +1h doxycycline, replicate 2, sequencing run 2 Capture-C in E14 (TOT2N…
- GSM8966041 Capture-C in E14 (TOT2N variant) cells with TetR-MybTA construct +1h doxycycline, replicate 2, sequencing run 3 Capture-C in E14 (TOT2N…
- GSM8966042 Capture-C in E14 (TOT2N variant) cells with TetR-MybTA construct +1h doxycycline, replicate 3, sequencing run 1 Capture-C in E14 (TOT2N…
- GSM8966043 Capture-C in E14 (TOT2N variant) cells with TetR-MybTA construct +1h doxycycline, replicate 3, sequencing run 2 Capture-C in E14 (TOT2N…
- GSM8966044 Capture-C in E14 (TOT2N variant) cells with TetR-MybTA construct +1h doxycycline, replicate 3, sequencing run 3 Capture-C in E14 (TOT2N…
- GSM8966045 Capture-C in E14 (TOT2N variant) cells with TetR-MybTA construct +24h doxcycline, replicate 1, sequencing run 1
- GSM8966046 Capture-C in E14 (TOT2N variant) cells with TetR-MybTA construct +24h doxycycline, replicate 1, sequencing run 2 Capture-C in E14 (TOT2N…
- GSM8966047 Capture-C in E14 (TOT2N variant) cells with TetR-MybTA construct +24h doxycycline, replicate 1, sequencing run 3 Capture-C in E14 (TOT2N…
- GSM8966048 Capture-C in E14 (TOT2N variant) cells with TetR-MybTA construct +24h doxycycline, replicate 2, sequencing run 1 Capture-C in E14 (TOT2N…
- GSM8966049 Capture-C in E14 (TOT2N variant) cells with TetR-MybTA construct +24h doxycycline, replicate 2, sequencing run 2 Capture-C in E14 (TOT2N…
- GSM8966050 Capture-C in E14 (TOT2N variant) cells with TetR-MybTA construct +24h doxycycline, replicate 2, sequencing run 3 Capture-C in E14 (TOT2N…
- GSM8966051 Capture-C in E14 (TOT2N variant) cells with TetR-MybTA construct +24h doxycycline, replicate 3, sequencing run 1 Capture-C in E14 (TOT2N…
+ 41 more — browse all 81 samples with per-sample file links →
- GSE240603 An eRNA Transcription Checkpoint For Diverse Signal-dependent Enhancer Activation Programs 144 samples shares activation, enhancer
- GSE240599 An eRNA Transcription Checkpoint For Diverse Signal-dependent Enhancer Activation Programs 130 samples shares activation, enhancer
- GSE292300 A core transcriptional regulatory circuitry controls super-enhancer-driven activation of LGR5 in colorectal cancer: ChIP-seq 76 samples shares activation, enhancer
- GSE292302 A core transcriptional regulatory circuitry controls super-enhancer-driven activation of LGR5 in colorectal cancer: RNA-seq 42 samples shares activation, enhancer
- GSE66383 Disruptions of Topological Chromatin Domains Causes Pathogenic Rewiring of Gene-Enhancer Interactions 31 samples shares interactions, enhancer
- GSE99519 YY1 is a structural regulator of enhancer-promoter loops [HiChIP] 17 samples shares enhancer-promoter, enhancer
- GSE261536 BPDCN MYB Fusions Regulate Cell Cycle Genes, Impair Differentiation and Induce Myeloid-Dendritic Cell Leukemia 124 samples shares myb
- GSE270431 Neutrophils recruited by NKX2-1 suppression via activation of CXCLs/CXCR2 axis promote lung adenocarcinoma progression 12 samples shares activation
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.